Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
12.76
-1.48 (-10.39%)
At close: Sep 3, 2026, 4:00 PM EDT
12.90
+0.14 (1.10%)
Pre-market: Sep 4, 2026, 6:15 AM EDT
Immunic Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Immunic stock has a consensus rating of "Strong Buy" and an average price target of $43.09. The average 1-year stock price forecast is 237.70% higher than the current stock price, while the lowest is $22 (+72.41%) and the highest is $85 (+566.14%).
Price Target: $43.09 (+237.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 10 | 11 | 12 | 12 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 10 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $27 | Buy | Maintains | $27 | +111.60% | Sep 2, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $56 | Buy | Maintains | $56 | +338.87% | Sep 1, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $19 → $29 | Buy | Reiterates | $19 → $29 | +127.27% | Sep 1, 2026 |
| Wedbush | Wedbush | Buy Initiates $45 | Buy | Initiates | $45 | +252.66% | Aug 17, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $22 | Buy | Reiterates | $22 | +72.41% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.57
from -6.20
EPS Next Year
-2.43
from -3.57
EPS and Forward PE are based on non-GAAP adjusted numbers.